Viewing StudyNCT03047083



Ignite Creation Date: 2024-05-06 @ 9:41 AM
Last Modification Date: 2024-10-26 @ 12:18 PM
Study NCT ID: NCT03047083
Status: COMPLETED
Last Update Posted: 2022-01-26
First Post: 2017-02-06

Brief Title: Treatment Patterns and Key Healthcare Resource Use in Acute Myeloid Leukemia AML With or Without FMS-like Tyrosine Kinase-3 FLT3 Mutation Study Based on Retrospective Chart Review
Sponsor: Astellas Pharma Global Development Inc
Organization: Astellas Pharma Inc

Key Dates - Follows AllAPIJSON File Order

Start Date: 2014-06-02
Start Date Type: ACTUAL
Primary Completion Date: 2016-03-18
Primary Completion Date Type: ACTUAL
Completion Date: 2016-03-18
Completion Date Type: ACTUAL
First Submit Date: 2017-02-06
First Submit QC Date: February 6 2017
Study First Post Date: 2017-02-08
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2022-01-25
Last Update Post Date: 2022-01-26
Last Update Post Date Type: ACTUAL